{
  "markdown": "<a id='b6ecb705-d02b-4b29-9b73-7bd9e147f628'></a>\n\nIntestinal Failure Associated Liver Disease (IFALD)\n\n<a id='3f25d752-6eea-4504-ba31-457a10ea6d1b'></a>\n\n- IFALD is seen in up to 2/3rds of patients on long-term PN\n- IFALD is defined as \"hepatobiliary dysfunction as a consequence of medical and surgical management strategies for intestinal failure which can variably progress to end-stage liver disease or can be stabilized or reversed with promotion of intestinal adaptation.\"\n- Many factors contribute to the development of IFALD\n\n<a id='4d0458ea-f232-43b0-b12f-223bafccec0a'></a>\n\n<::A diagram illustrating factors contributing to liver injury and liver protection. A large red downward-pointing arrow on the left is labeled \"Liver injury\" and lists the following factors:\noption Immature liver (prematurity): [x]\noption Early sepsis, NEC: [x]\noption Impaired bile acid recirculation (short gut): [x]\noption Bowel rest: [x]\noption Continuous PN related intestinal stasis: [x]\noption Phytosterols: [x]\n\nA large green upward-pointing arrow on the right is labeled \"Liver protection\" and lists the following factors:\noption Early oral/enteral feeding: [x]\noption Balanced parenteral energy and micronutrient supplies: [x]\noption Adapted aminoacid supply: [x]\noption Cyclic PN: [x]\noption Balanced fatty acid supply (ω-6/ω-3 ratio), fish oil: [x]\noption High α-tocopherol supply: [x]\n\nA yellow horizontal bar crosses diagonally from the bottom left to the top right, separating the two arrows.: diagram::>\n\n<a id='2a581be9-5687-4bb8-bd29-1f89e2e6dd05'></a>\n\n<::NASPGHAN FOUNDATION logo with a blue gradient background.::>\n\n<a id='f6e03fa9-820c-4e5c-a397-98ab55e5c604'></a>\n\nKocoshis SA. Semin Pediatr Surg. 2010;19:20-6.\n\n<a id='ea4058a5-ac78-489a-8b11-e8e6d1458c6e'></a>\n\nNorsa L, et al. Nutrients 2018;10:664.\n\n<a id='d270c4cf-072b-444d-9f6a-62dfa45d2f51'></a>\n\nCAPTION ERROR\n\n<a id='1a2595a1-df51-41be-b60f-7d85f5f13a91'></a>\n\nPN in Intestinal Failure\n\n* Multifactorial etiology\n\n<a id='32889cfe-4935-48e1-ad7b-1c9e72835218'></a>\n\n- Macronutrient excess promotes hepatic steatosis\n  - High GIR result in increased insulin, triggering hepatic lipogenesis\n  - Target required energy for disease state\n  - Balance nonprotein calories: 75% as carbohydrate, 25% as fat\n\n<a id='d59186bf-bc7c-4843-9663-c35e33a24488'></a>\n\n* High cumulative infusion of amino acids may also play a role\n  * Use of PN amino acid solutions designed for children to avoid nitrogen excess is advised\n  * Blood urea nitrogen, acidosis, nitrogen balance and growth can be monitored\n\n<a id='a206841d-ab19-43b7-9fba-db7138509a3b'></a>\n\n<::NASPGHAN FOUNDATION\n: figure::>\n\n<a id='1d4ee8ad-5aa7-40a9-9c69-a8937277e72e'></a>\n\nLacaille F, et al. J Pediatr Gastroenterol Nutr. 2015;60:272-83.\n\n<a id='d5cd2621-791c-4746-844e-fc0939eb9aa5'></a>\n\nCAPTION ERROR\n\n<a id='21898e66-f55d-4f31-8ff4-c6560d8f9c41'></a>\n\n# Lipid Emulsions and IFALD\n\n*   Soy based intravenous lipid emulsions (ILE) contain high w-6 long-chain polyunsaturated fatty acids (PUFA), phytosterols and low antioxidant content which promote inflammation and worsen cholestasis\n*   Discontinuation or minimizing pure soybean oil lipid emulsions (typically to 1 g/kg/day) may reverse cholestasis\n    *   Risk of EFAD and compromised growth\n\n<a id='8c4b4004-08fe-4ea1-9e90-03ae9a638659'></a>\n\n<::NASPGHAN FOUNDATION logo\n: figure::>\n\n<a id='5b69ca3d-d693-48cf-abf4-a128767b9105'></a>\n\nSilverman JA, et al. Pediatr Gastroenterol Nutr. 2020;71:283-7.\nColomb V, et al. J Parenter Enteral Nutr. 2000;24:945-50.\nPuder M, et al. Ann Surg. 2009;250:395-402.\n\n<a id='4eac19e0-ea94-4853-8b5f-517c818b201b'></a>\n\nCAPTION ERROR\n\n<a id='802835d2-4bdb-449f-bcbf-b73fe8debed8'></a>\n\n## Lipid Emulsions and IFALD – Cont'd\n\n* Composite lipid emulsions (containing soy, medium chain triglycerides, olive oil and fish oil) provider higher ω-3 to ω-6 fatty acid ratio, increased antioxidants through α-tocopherol and less phytosterols\n* Helps prevent and possibly treat IFALD in infants and children\n\n<a id='229f6f3c-5ac0-4d6b-97d2-9a992e52b520'></a>\n\n* Fish oil emulsions provide ω-3 PUFA, DHA and EHA, α-tocopherol and reduced phytosterol load and have been shown to reverse cholestasis\n* Typically dosed at 1g/kg/day; doses of 1.5-2 g/kg/day have been used off label to decrease GIR\n\n<a id='c710f76c-765f-4bc2-aeca-bdb26840bdb5'></a>\n\n<::NASPGHAN FOUNDATION\n: figure::>\n\n<a id='26f3cce6-a6ec-4353-87c3-184eaaeb0e46'></a>\n\nSilverman JA, et al. Pediatr Gastroenterol Nutr. 2020;71:283-7.\nColomb V, et al. J Parenter Enteral Nutr. 2000;24:945-50.\nPuder M, et al. Ann Surg. 2009;250:395-402.\n\n<a id='f4d0e5b7-5ba6-47ea-897e-d39a9dfb255d'></a>\n\nCAPTION ERROR\n\n<a id='06315174-9d22-4771-93ce-6729350937b7'></a>\n\nIntestinal Failure Nutritional Considerations\n\n* Start enteral feeds as soon as possible and advance as tolerated\n* Cycle PN when possible\n* PN is used to meet energy needs and promote normal growth\n  * The patient's response is best and PN should be adjusted to meet nutritional needs and promote normal growth\n  * Avoid overfeeding\n* Care within multidisciplinary intestinal rehabilitation teams is beneficial\n\n<a id='9b0a35bb-9c25-4269-9c09-82581c55e3c7'></a>\n\nNASPGHAN\nFOUNDATION\n\n<a id='f357e6e0-8a21-48a2-927c-36a0d14045ff'></a>\n\nLacaille F, et al. J Pediatr Gastroenterol Nutr. 2015;60:272-83.\n\n<a id='97ee7fbc-8e6a-43cc-975c-90dfd6434ef7'></a>\n\n<::logo: NASPGHAN\nNASPGHAN\nThe logo features the dark blue, bold, italicized text \"NASPGHAN\" on a light blue gradient background, with a dark blue curved line sweeping underneath the text from the right side.::>\n\n<a id='a2e7ab1c-6bd8-4a1f-b924-1f2bd19517af'></a>\n\n<::logo: Case\nCase\nA blue rectangular background with white text.::>\n\n<a id='c5ce4245-51bb-468e-9cb6-dbecaa21eec3'></a>\n\nLucy is a 5-month-old with biliary atresia and progressive end stage liver disease who is listed for transplant. She has been admitted on the GI ward for enteral nutrition to treat worsening malnutrition, however, is now transferred to PICU with fever, tachycardia, poor peripheral perfusion and hypoxia, requiring sedation and mechanical ventilation.\n\n<a id='5f193882-2745-4028-9cac-b2c7b3ed0b1f'></a>\n\n1) What information would you like to assess her nutrition?\n2) Would you recommend parenteral nutrition and when?\n3) What factors would influence the energy requirements of this patient?\n\n<a id='cd5efe5d-99fb-42fb-9cb0-f9ee579a5bc0'></a>\n\n<::NASPGHAN FOUNDATION\n: figure::>\n\n<a id='26e5838f-2ff6-4092-a4e6-26a9b208dbfe'></a>\n\n<::logo: NASPGHAN\nNASPGHAN\nThe logo features the dark blue, italicized text \"NASPGHAN\" on a light blue gradient background, with a dark blue curved line beneath the text.:>\n\n<a id='a06e1c3b-cb6e-4a28-ba5e-6f636bac1f97'></a>\n\nCase Review\n\n<a id='b5f31991-eeb7-4153-98a7-419f75e12005'></a>\n\nLucy is a 5-month-old with biliary atresia and progressive end stage liver\ndisea 1) What information would you like to assess her nutrition? ward\nfor er\ntrans\nhypo\n\noption Anthropometrics like weight, length, weight for length, head circumference; ideally additional measures of body composition like MUAC; recent growth trends: [x]\noption Feeding history, including feeding tolerance, vomiting, diarrhea: [x]\noption Presence of ascites that can impact feeding tolerance and weight interpretation: [x]\noption CRP at admission: [x]\n\nand\n\n1) V\n2) V\n3) V\nient?\n\n<a id='6d4a63c5-75b8-45f8-ade5-63f11ec2e5f7'></a>\n\nNASPGHAN\nFOUNDATION\n\n<a id='6983e46a-a8f9-4898-99ca-2292ae1303c1'></a>\n\n<::logo: NASPGHAN\nNASPGHAN\nThe logo features the dark blue, italicized text \"NASPGHAN\" on a blue gradient background, with a dark blue curved line underneath.::>\n\n<a id='e24ede4b-28f4-422f-8d9d-a456d3220f06'></a>\n\nCase Review Cont'd\n\n<a id='d74315ce-3ebb-4734-be3a-b83150a0808b'></a>\n\nLucy is a 5-month-old with biliary atresia and progressive end stage liver\ndisease who is listed for transplant. She has been admitted on the GI ward\nfor emergency admission and management of malnutrition and\nhypoglycemia.\n\n2) Would you recommend parenteral nutrition and when?\nShould recommence enteral nutrition support ideally within 24h\nand plan to advance to meet 60% of expected or ideally measured\nenergy requirements within a week. However, if not meeting daily\ngoals for EN deliver or experiencing significant feeding intolerance\nreasonable to consider starting PN in 72h\n\n1) [illegible]\n2) Would you recommend parenteral nutrition and when?\n3) What factors would influence the energy requirements of this patient?\n\n<a id='df9c0e3a-80d5-4cc6-9098-248f86bc96ef'></a>\n\n<::NASPGHAN FOUNDATION\n: figure::>\n\n<a id='95636053-c724-4c0f-b281-3cffd6a7fda8'></a>\n\n<::logo: NASPGHAN\nNASPGHAN\nThe logo features dark blue, italicized text \"NASPGHAN\" on a blue gradient background, with a dark blue curved line underneath.::>\n\n<a id='7a02331a-0056-4c9a-89fb-7e73fc51a505'></a>\n\nCase Review Cont'd\n\n<a id='4cca289f-5046-485b-a49e-9055b1a5b5b1'></a>\n\nLucy is a 5-month-old with biliary atresia and progressive end stage liver disease who is listed for transplant. She has been admitted on the GI ward\n\n3) What factors would influence the energy requirements of this patient?\noption Energy requirements are generally increased in liver failure: [x]\noption Sepsis can also increase energy requirements: [x]\noption Sedation and mechanical ventilation will both decrease energy needs: [x]\noption NPO and use of PN will also decrease total energy requirements: [x]\n\n1) What information would you like to assess her nutrition?\n2) Would you recommend parenteral nutrition and when?\n3) What factors would influence the energy requirements of this patient?\n\n<a id='da34bc69-6618-47a7-a65f-773452bb0f61'></a>\n\n<::NASPGHAN FOUNDATION\n: figure::>\n\n<a id='eeddfdb6-e47e-4dac-9201-207177434831'></a>\n\nCAPTION ERROR",
  "chunks": [
    {
      "markdown": "<a id='b6ecb705-d02b-4b29-9b73-7bd9e147f628'></a>\n\nIntestinal Failure Associated Liver Disease (IFALD)",
      "type": "text",
      "id": "b6ecb705-d02b-4b29-9b73-7bd9e147f628",
      "grounding": {
        "box": {
          "left": 0.06821951270103455,
          "top": 0.09378895908594131,
          "right": 0.8928407430648804,
          "bottom": 0.18533235788345337
        },
        "page": 0
      }
    },
    {
      "markdown": "<a id='3f25d752-6eea-4504-ba31-457a10ea6d1b'></a>\n\n- IFALD is seen in up to 2/3rds of patients on long-term PN\n- IFALD is defined as \"hepatobiliary dysfunction as a consequence of medical and surgical management strategies for intestinal failure which can variably progress to end-stage liver disease or can be stabilized or reversed with promotion of intestinal adaptation.\"\n- Many factors contribute to the development of IFALD",
      "type": "text",
      "id": "3f25d752-6eea-4504-ba31-457a10ea6d1b",
      "grounding": {
        "box": {
          "left": 0.06594036519527435,
          "top": 0.21393156051635742,
          "right": 0.5121729969978333,
          "bottom": 0.8586722612380981
        },
        "page": 0
      }
    },
    {
      "markdown": "<a id='4d0458ea-f232-43b0-b12f-223bafccec0a'></a>\n\n<::A diagram illustrating factors contributing to liver injury and liver protection. A large red downward-pointing arrow on the left is labeled \"Liver injury\" and lists the following factors:\noption Immature liver (prematurity): [x]\noption Early sepsis, NEC: [x]\noption Impaired bile acid recirculation (short gut): [x]\noption Bowel rest: [x]\noption Continuous PN related intestinal stasis: [x]\noption Phytosterols: [x]\n\nA large green upward-pointing arrow on the right is labeled \"Liver protection\" and lists the following factors:\noption Early oral/enteral feeding: [x]\noption Balanced parenteral energy and micronutrient supplies: [x]\noption Adapted aminoacid supply: [x]\noption Cyclic PN: [x]\noption Balanced fatty acid supply (ω-6/ω-3 ratio), fish oil: [x]\noption High α-tocopherol supply: [x]\n\nA yellow horizontal bar crosses diagonally from the bottom left to the top right, separating the two arrows.: diagram::>",
      "type": "figure",
      "id": "4d0458ea-f232-43b0-b12f-223bafccec0a",
      "grounding": {
        "box": {
          "left": 0.5416315793991089,
          "top": 0.20940187573432922,
          "right": 0.9348140954971313,
          "bottom": 0.8764520883560181
        },
        "page": 0
      }
    },
    {
      "markdown": "<a id='2a581be9-5687-4bb8-bd29-1f89e2e6dd05'></a>\n\n<::NASPGHAN FOUNDATION logo with a blue gradient background.::>",
      "type": "figure",
      "id": "2a581be9-5687-4bb8-bd29-1f89e2e6dd05",
      "grounding": {
        "box": {
          "left": 0.00045027583837509155,
          "top": 0.8965668678283691,
          "right": 0.1548824906349182,
          "bottom": 0.9983819723129272
        },
        "page": 0
      }
    },
    {
      "markdown": "<a id='f6e03fa9-820c-4e5c-a397-98ab55e5c604'></a>\n\nKocoshis SA. Semin Pediatr Surg. 2010;19:20-6.",
      "type": "text",
      "id": "f6e03fa9-820c-4e5c-a397-98ab55e5c604",
      "grounding": {
        "box": {
          "left": 0.16332238912582397,
          "top": 0.913303554058075,
          "right": 0.45221132040023804,
          "bottom": 0.9615463614463806
        },
        "page": 0
      }
    },
    {
      "markdown": "<a id='ea4058a5-ac78-489a-8b11-e8e6d1458c6e'></a>\n\nNorsa L, et al. Nutrients 2018;10:664.",
      "type": "text",
      "id": "ea4058a5-ac78-489a-8b11-e8e6d1458c6e",
      "grounding": {
        "box": {
          "left": 0.642351508140564,
          "top": 0.8726059794425964,
          "right": 0.8599236011505127,
          "bottom": 0.9092616438865662
        },
        "page": 0
      }
    },
    {
      "markdown": "<a id='d270c4cf-072b-444d-9f6a-62dfa45d2f51'></a>\n\nCAPTION ERROR",
      "type": "logo",
      "id": "d270c4cf-072b-444d-9f6a-62dfa45d2f51",
      "grounding": {
        "box": {
          "left": 0.8062930107116699,
          "top": 0.895202100276947,
          "right": 0.9973379373550415,
          "bottom": 0.999583899974823
        },
        "page": 0
      }
    },
    {
      "markdown": "<a id='1a2595a1-df51-41be-b60f-7d85f5f13a91'></a>\n\nPN in Intestinal Failure\n\n* Multifactorial etiology",
      "type": "text",
      "id": "1a2595a1-df51-41be-b60f-7d85f5f13a91",
      "grounding": {
        "box": {
          "left": 0.06475400924682617,
          "top": 0.10816587507724762,
          "right": 0.47577887773513794,
          "bottom": 0.2736901044845581
        },
        "page": 1
      }
    },
    {
      "markdown": "<a id='32889cfe-4935-48e1-ad7b-1c9e72835218'></a>\n\n- Macronutrient excess promotes hepatic steatosis\n  - High GIR result in increased insulin, triggering hepatic lipogenesis\n  - Target required energy for disease state\n  - Balance nonprotein calories: 75% as carbohydrate, 25% as fat",
      "type": "text",
      "id": "32889cfe-4935-48e1-ad7b-1c9e72835218",
      "grounding": {
        "box": {
          "left": 0.06796503067016602,
          "top": 0.3211227059364319,
          "right": 0.8049461245536804,
          "bottom": 0.5625595450401306
        },
        "page": 1
      }
    },
    {
      "markdown": "<a id='d59186bf-bc7c-4843-9663-c35e33a24488'></a>\n\n* High cumulative infusion of amino acids may also play a role\n  * Use of PN amino acid solutions designed for children to avoid nitrogen excess is advised\n  * Blood urea nitrogen, acidosis, nitrogen balance and growth can be monitored",
      "type": "text",
      "id": "d59186bf-bc7c-4843-9663-c35e33a24488",
      "grounding": {
        "box": {
          "left": 0.06891018152236938,
          "top": 0.5991585850715637,
          "right": 0.9284107685089111,
          "bottom": 0.8322474360466003
        },
        "page": 1
      }
    },
    {
      "markdown": "<a id='a206841d-ab19-43b7-9fba-db7138509a3b'></a>\n\n<::NASPGHAN FOUNDATION\n: figure::>",
      "type": "figure",
      "id": "a206841d-ab19-43b7-9fba-db7138509a3b",
      "grounding": {
        "box": {
          "left": 0.0004724264144897461,
          "top": 0.8985068202018738,
          "right": 0.15385374426841736,
          "bottom": 0.9989102482795715
        },
        "page": 1
      }
    },
    {
      "markdown": "<a id='1d4ee8ad-5aa7-40a9-9c69-a8937277e72e'></a>\n\nLacaille F, et al. J Pediatr Gastroenterol Nutr. 2015;60:272-83.",
      "type": "text",
      "id": "1d4ee8ad-5aa7-40a9-9c69-a8937277e72e",
      "grounding": {
        "box": {
          "left": 0.16370706260204315,
          "top": 0.9119826555252075,
          "right": 0.5361854434013367,
          "bottom": 0.9597796201705933
        },
        "page": 1
      }
    },
    {
      "markdown": "<a id='d5cd2621-791c-4746-844e-fc0939eb9aa5'></a>\n\nCAPTION ERROR",
      "type": "logo",
      "id": "d5cd2621-791c-4746-844e-fc0939eb9aa5",
      "grounding": {
        "box": {
          "left": 0.8060640096664429,
          "top": 0.8947970271110535,
          "right": 0.9978591203689575,
          "bottom": 0.9997079968452454
        },
        "page": 1
      }
    },
    {
      "markdown": "<a id='21898e66-f55d-4f31-8ff4-c6560d8f9c41'></a>\n\n# Lipid Emulsions and IFALD\n\n*   Soy based intravenous lipid emulsions (ILE) contain high w-6 long-chain polyunsaturated fatty acids (PUFA), phytosterols and low antioxidant content which promote inflammation and worsen cholestasis\n*   Discontinuation or minimizing pure soybean oil lipid emulsions (typically to 1 g/kg/day) may reverse cholestasis\n    *   Risk of EFAD and compromised growth",
      "type": "text",
      "id": "21898e66-f55d-4f31-8ff4-c6560d8f9c41",
      "grounding": {
        "box": {
          "left": 0.06251382827758789,
          "top": 0.10470589995384216,
          "right": 0.9192966222763062,
          "bottom": 0.6845964193344116
        },
        "page": 2
      }
    },
    {
      "markdown": "<a id='8c4b4004-08fe-4ea1-9e90-03ae9a638659'></a>\n\n<::NASPGHAN FOUNDATION logo\n: figure::>",
      "type": "figure",
      "id": "8c4b4004-08fe-4ea1-9e90-03ae9a638659",
      "grounding": {
        "box": {
          "left": 0.0003286302089691162,
          "top": 0.897782027721405,
          "right": 0.15225020051002502,
          "bottom": 0.9992154240608215
        },
        "page": 2
      }
    },
    {
      "markdown": "<a id='5b69ca3d-d693-48cf-abf4-a128767b9105'></a>\n\nSilverman JA, et al. Pediatr Gastroenterol Nutr. 2020;71:283-7.\nColomb V, et al. J Parenter Enteral Nutr. 2000;24:945-50.\nPuder M, et al. Ann Surg. 2009;250:395-402.",
      "type": "text",
      "id": "5b69ca3d-d693-48cf-abf4-a128767b9105",
      "grounding": {
        "box": {
          "left": 0.16136549413204193,
          "top": 0.8928555250167847,
          "right": 0.5391477346420288,
          "bottom": 0.9975388050079346
        },
        "page": 2
      }
    },
    {
      "markdown": "<a id='4eac19e0-ea94-4853-8b5f-517c818b201b'></a>\n\nCAPTION ERROR",
      "type": "logo",
      "id": "4eac19e0-ea94-4853-8b5f-517c818b201b",
      "grounding": {
        "box": {
          "left": 0.8055374026298523,
          "top": 0.8962593078613281,
          "right": 0.9983918070793152,
          "bottom": 0.9997262954711914
        },
        "page": 2
      }
    },
    {
      "markdown": "<a id='802835d2-4bdb-449f-bcbf-b73fe8debed8'></a>\n\n## Lipid Emulsions and IFALD – Cont'd\n\n* Composite lipid emulsions (containing soy, medium chain triglycerides, olive oil and fish oil) provider higher ω-3 to ω-6 fatty acid ratio, increased antioxidants through α-tocopherol and less phytosterols\n* Helps prevent and possibly treat IFALD in infants and children",
      "type": "text",
      "id": "802835d2-4bdb-449f-bcbf-b73fe8debed8",
      "grounding": {
        "box": {
          "left": 0.06367933750152588,
          "top": 0.10384915769100189,
          "right": 0.8908818960189819,
          "bottom": 0.530711829662323
        },
        "page": 3
      }
    },
    {
      "markdown": "<a id='229f6f3c-5ac0-4d6b-97d2-9a992e52b520'></a>\n\n* Fish oil emulsions provide ω-3 PUFA, DHA and EHA, α-tocopherol and reduced phytosterol load and have been shown to reverse cholestasis\n* Typically dosed at 1g/kg/day; doses of 1.5-2 g/kg/day have been used off label to decrease GIR",
      "type": "text",
      "id": "229f6f3c-5ac0-4d6b-97d2-9a992e52b520",
      "grounding": {
        "box": {
          "left": 0.0692303478717804,
          "top": 0.5710016489028931,
          "right": 0.9251737594604492,
          "bottom": 0.8231790065765381
        },
        "page": 3
      }
    },
    {
      "markdown": "<a id='c710f76c-765f-4bc2-aeca-bdb26840bdb5'></a>\n\n<::NASPGHAN FOUNDATION\n: figure::>",
      "type": "figure",
      "id": "c710f76c-765f-4bc2-aeca-bdb26840bdb5",
      "grounding": {
        "box": {
          "left": 0.00039771199226379395,
          "top": 0.8972253203392029,
          "right": 0.15179015696048737,
          "bottom": 0.9992945790290833
        },
        "page": 3
      }
    },
    {
      "markdown": "<a id='26f3cce6-a6ec-4353-87c3-184eaaeb0e46'></a>\n\nSilverman JA, et al. Pediatr Gastroenterol Nutr. 2020;71:283-7.\nColomb V, et al. J Parenter Enteral Nutr. 2000;24:945-50.\nPuder M, et al. Ann Surg. 2009;250:395-402.",
      "type": "text",
      "id": "26f3cce6-a6ec-4353-87c3-184eaaeb0e46",
      "grounding": {
        "box": {
          "left": 0.16185934841632843,
          "top": 0.8927229642868042,
          "right": 0.5390763282775879,
          "bottom": 0.997846245765686
        },
        "page": 3
      }
    },
    {
      "markdown": "<a id='f4d0e5b7-5ba6-47ea-897e-d39a9dfb255d'></a>\n\nCAPTION ERROR",
      "type": "logo",
      "id": "f4d0e5b7-5ba6-47ea-897e-d39a9dfb255d",
      "grounding": {
        "box": {
          "left": 0.8052676916122437,
          "top": 0.8951627612113953,
          "right": 0.998414158821106,
          "bottom": 0.9996880888938904
        },
        "page": 3
      }
    },
    {
      "markdown": "<a id='06315174-9d22-4771-93ce-6729350937b7'></a>\n\nIntestinal Failure Nutritional Considerations\n\n* Start enteral feeds as soon as possible and advance as tolerated\n* Cycle PN when possible\n* PN is used to meet energy needs and promote normal growth\n  * The patient's response is best and PN should be adjusted to meet nutritional needs and promote normal growth\n  * Avoid overfeeding\n* Care within multidisciplinary intestinal rehabilitation teams is beneficial",
      "type": "text",
      "id": "06315174-9d22-4771-93ce-6729350937b7",
      "grounding": {
        "box": {
          "left": 0.06245806813240051,
          "top": 0.10587182641029358,
          "right": 0.9247637987136841,
          "bottom": 0.8017771244049072
        },
        "page": 4
      }
    },
    {
      "markdown": "<a id='9b0a35bb-9c25-4269-9c09-82581c55e3c7'></a>\n\nNASPGHAN\nFOUNDATION",
      "type": "text",
      "id": "9b0a35bb-9c25-4269-9c09-82581c55e3c7",
      "grounding": {
        "box": {
          "left": 0.0003002285957336426,
          "top": 0.8995340466499329,
          "right": 0.15346208214759827,
          "bottom": 0.9984896779060364
        },
        "page": 4
      }
    },
    {
      "markdown": "<a id='f357e6e0-8a21-48a2-927c-36a0d14045ff'></a>\n\nLacaille F, et al. J Pediatr Gastroenterol Nutr. 2015;60:272-83.",
      "type": "text",
      "id": "f357e6e0-8a21-48a2-927c-36a0d14045ff",
      "grounding": {
        "box": {
          "left": 0.1642737090587616,
          "top": 0.9128892421722412,
          "right": 0.5352658033370972,
          "bottom": 0.9591253995895386
        },
        "page": 4
      }
    },
    {
      "markdown": "<a id='97ee7fbc-8e6a-43cc-975c-90dfd6434ef7'></a>\n\n<::logo: NASPGHAN\nNASPGHAN\nThe logo features the dark blue, bold, italicized text \"NASPGHAN\" on a light blue gradient background, with a dark blue curved line sweeping underneath the text from the right side.::>",
      "type": "logo",
      "id": "97ee7fbc-8e6a-43cc-975c-90dfd6434ef7",
      "grounding": {
        "box": {
          "left": 0.8064997792243958,
          "top": 0.896197497844696,
          "right": 0.9977017045021057,
          "bottom": 0.9995390772819519
        },
        "page": 4
      }
    },
    {
      "markdown": "<a id='a2e7ab1c-6bd8-4a1f-b924-1f2bd19517af'></a>\n\n<::logo: Case\nCase\nA blue rectangular background with white text.::>",
      "type": "logo",
      "id": "a2e7ab1c-6bd8-4a1f-b924-1f2bd19517af",
      "grounding": {
        "box": {
          "left": 0.06726927310228348,
          "top": 0.10347624123096466,
          "right": 0.16528275609016418,
          "bottom": 0.17649449408054352
        },
        "page": 5
      }
    },
    {
      "markdown": "<a id='c5ce4245-51bb-468e-9cb6-dbecaa21eec3'></a>\n\nLucy is a 5-month-old with biliary atresia and progressive end stage liver disease who is listed for transplant. She has been admitted on the GI ward for enteral nutrition to treat worsening malnutrition, however, is now transferred to PICU with fever, tachycardia, poor peripheral perfusion and hypoxia, requiring sedation and mechanical ventilation.",
      "type": "text",
      "id": "c5ce4245-51bb-468e-9cb6-dbecaa21eec3",
      "grounding": {
        "box": {
          "left": 0.06566044688224792,
          "top": 0.23982617259025574,
          "right": 0.967273473739624,
          "bottom": 0.5444543361663818
        },
        "page": 5
      }
    },
    {
      "markdown": "<a id='5f193882-2745-4028-9cac-b2c7b3ed0b1f'></a>\n\n1) What information would you like to assess her nutrition?\n2) Would you recommend parenteral nutrition and when?\n3) What factors would influence the energy requirements of this patient?",
      "type": "text",
      "id": "5f193882-2745-4028-9cac-b2c7b3ed0b1f",
      "grounding": {
        "box": {
          "left": 0.0797649621963501,
          "top": 0.5974393486976624,
          "right": 0.9643352031707764,
          "bottom": 0.8133531212806702
        },
        "page": 5
      }
    },
    {
      "markdown": "<a id='cd5efe5d-99fb-42fb-9cb0-f9ee579a5bc0'></a>\n\n<::NASPGHAN FOUNDATION\n: figure::>",
      "type": "figure",
      "id": "cd5efe5d-99fb-42fb-9cb0-f9ee579a5bc0",
      "grounding": {
        "box": {
          "left": 0.0001544356346130371,
          "top": 0.8970438838005066,
          "right": 0.15438024699687958,
          "bottom": 0.9992749094963074
        },
        "page": 5
      }
    },
    {
      "markdown": "<a id='26e5838f-2ff6-4092-a4e6-26a9b208dbfe'></a>\n\n<::logo: NASPGHAN\nNASPGHAN\nThe logo features the dark blue, italicized text \"NASPGHAN\" on a light blue gradient background, with a dark blue curved line beneath the text.:>",
      "type": "logo",
      "id": "26e5838f-2ff6-4092-a4e6-26a9b208dbfe",
      "grounding": {
        "box": {
          "left": 0.8047690391540527,
          "top": 0.8942133784294128,
          "right": 0.9988257884979248,
          "bottom": 0.9997617602348328
        },
        "page": 5
      }
    },
    {
      "markdown": "<a id='a06e1c3b-cb6e-4a28-ba5e-6f636bac1f97'></a>\n\nCase Review",
      "type": "text",
      "id": "a06e1c3b-cb6e-4a28-ba5e-6f636bac1f97",
      "grounding": {
        "box": {
          "left": 0.06767409294843674,
          "top": 0.09902749955654144,
          "right": 0.3092477321624756,
          "bottom": 0.17833875119686127
        },
        "page": 6
      }
    },
    {
      "markdown": "<a id='b5f31991-eeb7-4153-98a7-419f75e12005'></a>\n\nLucy is a 5-month-old with biliary atresia and progressive end stage liver\ndisea 1) What information would you like to assess her nutrition? ward\nfor er\ntrans\nhypo\n\noption Anthropometrics like weight, length, weight for length, head circumference; ideally additional measures of body composition like MUAC; recent growth trends: [x]\noption Feeding history, including feeding tolerance, vomiting, diarrhea: [x]\noption Presence of ascites that can impact feeding tolerance and weight interpretation: [x]\noption CRP at admission: [x]\n\nand\n\n1) V\n2) V\n3) V\nient?",
      "type": "text",
      "id": "b5f31991-eeb7-4153-98a7-419f75e12005",
      "grounding": {
        "box": {
          "left": 0.06679633259773254,
          "top": 0.23899877071380615,
          "right": 0.9666863679885864,
          "bottom": 0.812995433807373
        },
        "page": 6
      }
    },
    {
      "markdown": "<a id='6d4a63c5-75b8-45f8-ade5-63f11ec2e5f7'></a>\n\nNASPGHAN\nFOUNDATION",
      "type": "text",
      "id": "6d4a63c5-75b8-45f8-ade5-63f11ec2e5f7",
      "grounding": {
        "box": {
          "left": 0.00015389174222946167,
          "top": 0.895706057548523,
          "right": 0.15380513668060303,
          "bottom": 0.9995803833007812
        },
        "page": 6
      }
    },
    {
      "markdown": "<a id='6983e46a-a8f9-4898-99ca-2292ae1303c1'></a>\n\n<::logo: NASPGHAN\nNASPGHAN\nThe logo features the dark blue, italicized text \"NASPGHAN\" on a blue gradient background, with a dark blue curved line underneath.::>",
      "type": "logo",
      "id": "6983e46a-a8f9-4898-99ca-2292ae1303c1",
      "grounding": {
        "box": {
          "left": 0.8054748773574829,
          "top": 0.892585813999176,
          "right": 0.9982607364654541,
          "bottom": 0.9998438954353333
        },
        "page": 6
      }
    },
    {
      "markdown": "<a id='e24ede4b-28f4-422f-8d9d-a456d3220f06'></a>\n\nCase Review Cont'd",
      "type": "text",
      "id": "e24ede4b-28f4-422f-8d9d-a456d3220f06",
      "grounding": {
        "box": {
          "left": 0.06822560727596283,
          "top": 0.09589503705501556,
          "right": 0.42074233293533325,
          "bottom": 0.18239276111125946
        },
        "page": 7
      }
    },
    {
      "markdown": "<a id='d74315ce-3ebb-4734-be3a-b83150a0808b'></a>\n\nLucy is a 5-month-old with biliary atresia and progressive end stage liver\ndisease who is listed for transplant. She has been admitted on the GI ward\nfor emergency admission and management of malnutrition and\nhypoglycemia.\n\n2) Would you recommend parenteral nutrition and when?\nShould recommence enteral nutrition support ideally within 24h\nand plan to advance to meet 60% of expected or ideally measured\nenergy requirements within a week. However, if not meeting daily\ngoals for EN deliver or experiencing significant feeding intolerance\nreasonable to consider starting PN in 72h\n\n1) [illegible]\n2) Would you recommend parenteral nutrition and when?\n3) What factors would influence the energy requirements of this patient?",
      "type": "text",
      "id": "d74315ce-3ebb-4734-be3a-b83150a0808b",
      "grounding": {
        "box": {
          "left": 0.06651273369789124,
          "top": 0.2409127950668335,
          "right": 0.966292142868042,
          "bottom": 0.8104273080825806
        },
        "page": 7
      }
    },
    {
      "markdown": "<a id='df9c0e3a-80d5-4cc6-9098-248f86bc96ef'></a>\n\n<::NASPGHAN FOUNDATION\n: figure::>",
      "type": "figure",
      "id": "df9c0e3a-80d5-4cc6-9098-248f86bc96ef",
      "grounding": {
        "box": {
          "left": 0.00012126564979553223,
          "top": 0.8968214988708496,
          "right": 0.15453636646270752,
          "bottom": 0.9994776248931885
        },
        "page": 7
      }
    },
    {
      "markdown": "<a id='95636053-c724-4c0f-b281-3cffd6a7fda8'></a>\n\n<::logo: NASPGHAN\nNASPGHAN\nThe logo features dark blue, italicized text \"NASPGHAN\" on a blue gradient background, with a dark blue curved line underneath.::>",
      "type": "logo",
      "id": "95636053-c724-4c0f-b281-3cffd6a7fda8",
      "grounding": {
        "box": {
          "left": 0.8047931790351868,
          "top": 0.8936476111412048,
          "right": 0.9984483122825623,
          "bottom": 0.9997597336769104
        },
        "page": 7
      }
    },
    {
      "markdown": "<a id='7a02331a-0056-4c9a-89fb-7e73fc51a505'></a>\n\nCase Review Cont'd",
      "type": "text",
      "id": "7a02331a-0056-4c9a-89fb-7e73fc51a505",
      "grounding": {
        "box": {
          "left": 0.06784297525882721,
          "top": 0.09457655996084213,
          "right": 0.4217453598976135,
          "bottom": 0.18201130628585815
        },
        "page": 8
      }
    },
    {
      "markdown": "<a id='4cca289f-5046-485b-a49e-9055b1a5b5b1'></a>\n\nLucy is a 5-month-old with biliary atresia and progressive end stage liver disease who is listed for transplant. She has been admitted on the GI ward\n\n3) What factors would influence the energy requirements of this patient?\noption Energy requirements are generally increased in liver failure: [x]\noption Sepsis can also increase energy requirements: [x]\noption Sedation and mechanical ventilation will both decrease energy needs: [x]\noption NPO and use of PN will also decrease total energy requirements: [x]\n\n1) What information would you like to assess her nutrition?\n2) Would you recommend parenteral nutrition and when?\n3) What factors would influence the energy requirements of this patient?",
      "type": "text",
      "id": "4cca289f-5046-485b-a49e-9055b1a5b5b1",
      "grounding": {
        "box": {
          "left": 0.06520622968673706,
          "top": 0.24003693461418152,
          "right": 0.9668915867805481,
          "bottom": 0.8125436305999756
        },
        "page": 8
      }
    },
    {
      "markdown": "<a id='da34bc69-6618-47a7-a65f-773452bb0f61'></a>\n\n<::NASPGHAN FOUNDATION\n: figure::>",
      "type": "figure",
      "id": "da34bc69-6618-47a7-a65f-773452bb0f61",
      "grounding": {
        "box": {
          "left": 3.2573938369750977e-05,
          "top": 0.8971733450889587,
          "right": 0.15463882684707642,
          "bottom": 0.9995041489601135
        },
        "page": 8
      }
    },
    {
      "markdown": "<a id='eeddfdb6-e47e-4dac-9201-207177434831'></a>\n\nCAPTION ERROR",
      "type": "logo",
      "id": "eeddfdb6-e47e-4dac-9201-207177434831",
      "grounding": {
        "box": {
          "left": 0.8047940135002136,
          "top": 0.8939814567565918,
          "right": 0.9987171292304993,
          "bottom": 0.999727725982666
        },
        "page": 8
      }
    }
  ],
  "splits": [
    {
      "class": "full",
      "identifier": "full",
      "pages": [
        0,
        1,
        2,
        3,
        4,
        5,
        6,
        7,
        8
      ],
      "markdown": "<a id='b6ecb705-d02b-4b29-9b73-7bd9e147f628'></a>\n\nIntestinal Failure Associated Liver Disease (IFALD)\n\n<a id='3f25d752-6eea-4504-ba31-457a10ea6d1b'></a>\n\n- IFALD is seen in up to 2/3rds of patients on long-term PN\n- IFALD is defined as \"hepatobiliary dysfunction as a consequence of medical and surgical management strategies for intestinal failure which can variably progress to end-stage liver disease or can be stabilized or reversed with promotion of intestinal adaptation.\"\n- Many factors contribute to the development of IFALD\n\n<a id='4d0458ea-f232-43b0-b12f-223bafccec0a'></a>\n\n<::A diagram illustrating factors contributing to liver injury and liver protection. A large red downward-pointing arrow on the left is labeled \"Liver injury\" and lists the following factors:\noption Immature liver (prematurity): [x]\noption Early sepsis, NEC: [x]\noption Impaired bile acid recirculation (short gut): [x]\noption Bowel rest: [x]\noption Continuous PN related intestinal stasis: [x]\noption Phytosterols: [x]\n\nA large green upward-pointing arrow on the right is labeled \"Liver protection\" and lists the following factors:\noption Early oral/enteral feeding: [x]\noption Balanced parenteral energy and micronutrient supplies: [x]\noption Adapted aminoacid supply: [x]\noption Cyclic PN: [x]\noption Balanced fatty acid supply (ω-6/ω-3 ratio), fish oil: [x]\noption High α-tocopherol supply: [x]\n\nA yellow horizontal bar crosses diagonally from the bottom left to the top right, separating the two arrows.: diagram::>\n\n<a id='2a581be9-5687-4bb8-bd29-1f89e2e6dd05'></a>\n\n<::NASPGHAN FOUNDATION logo with a blue gradient background.::>\n\n<a id='f6e03fa9-820c-4e5c-a397-98ab55e5c604'></a>\n\nKocoshis SA. Semin Pediatr Surg. 2010;19:20-6.\n\n<a id='ea4058a5-ac78-489a-8b11-e8e6d1458c6e'></a>\n\nNorsa L, et al. Nutrients 2018;10:664.\n\n<a id='d270c4cf-072b-444d-9f6a-62dfa45d2f51'></a>\n\nCAPTION ERROR\n\n<a id='1a2595a1-df51-41be-b60f-7d85f5f13a91'></a>\n\nPN in Intestinal Failure\n\n* Multifactorial etiology\n\n<a id='32889cfe-4935-48e1-ad7b-1c9e72835218'></a>\n\n- Macronutrient excess promotes hepatic steatosis\n  - High GIR result in increased insulin, triggering hepatic lipogenesis\n  - Target required energy for disease state\n  - Balance nonprotein calories: 75% as carbohydrate, 25% as fat\n\n<a id='d59186bf-bc7c-4843-9663-c35e33a24488'></a>\n\n* High cumulative infusion of amino acids may also play a role\n  * Use of PN amino acid solutions designed for children to avoid nitrogen excess is advised\n  * Blood urea nitrogen, acidosis, nitrogen balance and growth can be monitored\n\n<a id='a206841d-ab19-43b7-9fba-db7138509a3b'></a>\n\n<::NASPGHAN FOUNDATION\n: figure::>\n\n<a id='1d4ee8ad-5aa7-40a9-9c69-a8937277e72e'></a>\n\nLacaille F, et al. J Pediatr Gastroenterol Nutr. 2015;60:272-83.\n\n<a id='d5cd2621-791c-4746-844e-fc0939eb9aa5'></a>\n\nCAPTION ERROR\n\n<a id='21898e66-f55d-4f31-8ff4-c6560d8f9c41'></a>\n\n# Lipid Emulsions and IFALD\n\n*   Soy based intravenous lipid emulsions (ILE) contain high w-6 long-chain polyunsaturated fatty acids (PUFA), phytosterols and low antioxidant content which promote inflammation and worsen cholestasis\n*   Discontinuation or minimizing pure soybean oil lipid emulsions (typically to 1 g/kg/day) may reverse cholestasis\n    *   Risk of EFAD and compromised growth\n\n<a id='8c4b4004-08fe-4ea1-9e90-03ae9a638659'></a>\n\n<::NASPGHAN FOUNDATION logo\n: figure::>\n\n<a id='5b69ca3d-d693-48cf-abf4-a128767b9105'></a>\n\nSilverman JA, et al. Pediatr Gastroenterol Nutr. 2020;71:283-7.\nColomb V, et al. J Parenter Enteral Nutr. 2000;24:945-50.\nPuder M, et al. Ann Surg. 2009;250:395-402.\n\n<a id='4eac19e0-ea94-4853-8b5f-517c818b201b'></a>\n\nCAPTION ERROR\n\n<a id='802835d2-4bdb-449f-bcbf-b73fe8debed8'></a>\n\n## Lipid Emulsions and IFALD – Cont'd\n\n* Composite lipid emulsions (containing soy, medium chain triglycerides, olive oil and fish oil) provider higher ω-3 to ω-6 fatty acid ratio, increased antioxidants through α-tocopherol and less phytosterols\n* Helps prevent and possibly treat IFALD in infants and children\n\n<a id='229f6f3c-5ac0-4d6b-97d2-9a992e52b520'></a>\n\n* Fish oil emulsions provide ω-3 PUFA, DHA and EHA, α-tocopherol and reduced phytosterol load and have been shown to reverse cholestasis\n* Typically dosed at 1g/kg/day; doses of 1.5-2 g/kg/day have been used off label to decrease GIR\n\n<a id='c710f76c-765f-4bc2-aeca-bdb26840bdb5'></a>\n\n<::NASPGHAN FOUNDATION\n: figure::>\n\n<a id='26f3cce6-a6ec-4353-87c3-184eaaeb0e46'></a>\n\nSilverman JA, et al. Pediatr Gastroenterol Nutr. 2020;71:283-7.\nColomb V, et al. J Parenter Enteral Nutr. 2000;24:945-50.\nPuder M, et al. Ann Surg. 2009;250:395-402.\n\n<a id='f4d0e5b7-5ba6-47ea-897e-d39a9dfb255d'></a>\n\nCAPTION ERROR\n\n<a id='06315174-9d22-4771-93ce-6729350937b7'></a>\n\nIntestinal Failure Nutritional Considerations\n\n* Start enteral feeds as soon as possible and advance as tolerated\n* Cycle PN when possible\n* PN is used to meet energy needs and promote normal growth\n  * The patient's response is best and PN should be adjusted to meet nutritional needs and promote normal growth\n  * Avoid overfeeding\n* Care within multidisciplinary intestinal rehabilitation teams is beneficial\n\n<a id='9b0a35bb-9c25-4269-9c09-82581c55e3c7'></a>\n\nNASPGHAN\nFOUNDATION\n\n<a id='f357e6e0-8a21-48a2-927c-36a0d14045ff'></a>\n\nLacaille F, et al. J Pediatr Gastroenterol Nutr. 2015;60:272-83.\n\n<a id='97ee7fbc-8e6a-43cc-975c-90dfd6434ef7'></a>\n\n<::logo: NASPGHAN\nNASPGHAN\nThe logo features the dark blue, bold, italicized text \"NASPGHAN\" on a light blue gradient background, with a dark blue curved line sweeping underneath the text from the right side.::>\n\n<a id='a2e7ab1c-6bd8-4a1f-b924-1f2bd19517af'></a>\n\n<::logo: Case\nCase\nA blue rectangular background with white text.::>\n\n<a id='c5ce4245-51bb-468e-9cb6-dbecaa21eec3'></a>\n\nLucy is a 5-month-old with biliary atresia and progressive end stage liver disease who is listed for transplant. She has been admitted on the GI ward for enteral nutrition to treat worsening malnutrition, however, is now transferred to PICU with fever, tachycardia, poor peripheral perfusion and hypoxia, requiring sedation and mechanical ventilation.\n\n<a id='5f193882-2745-4028-9cac-b2c7b3ed0b1f'></a>\n\n1) What information would you like to assess her nutrition?\n2) Would you recommend parenteral nutrition and when?\n3) What factors would influence the energy requirements of this patient?\n\n<a id='cd5efe5d-99fb-42fb-9cb0-f9ee579a5bc0'></a>\n\n<::NASPGHAN FOUNDATION\n: figure::>\n\n<a id='26e5838f-2ff6-4092-a4e6-26a9b208dbfe'></a>\n\n<::logo: NASPGHAN\nNASPGHAN\nThe logo features the dark blue, italicized text \"NASPGHAN\" on a light blue gradient background, with a dark blue curved line beneath the text.:>\n\n<a id='a06e1c3b-cb6e-4a28-ba5e-6f636bac1f97'></a>\n\nCase Review\n\n<a id='b5f31991-eeb7-4153-98a7-419f75e12005'></a>\n\nLucy is a 5-month-old with biliary atresia and progressive end stage liver\ndisea 1) What information would you like to assess her nutrition? ward\nfor er\ntrans\nhypo\n\noption Anthropometrics like weight, length, weight for length, head circumference; ideally additional measures of body composition like MUAC; recent growth trends: [x]\noption Feeding history, including feeding tolerance, vomiting, diarrhea: [x]\noption Presence of ascites that can impact feeding tolerance and weight interpretation: [x]\noption CRP at admission: [x]\n\nand\n\n1) V\n2) V\n3) V\nient?\n\n<a id='6d4a63c5-75b8-45f8-ade5-63f11ec2e5f7'></a>\n\nNASPGHAN\nFOUNDATION\n\n<a id='6983e46a-a8f9-4898-99ca-2292ae1303c1'></a>\n\n<::logo: NASPGHAN\nNASPGHAN\nThe logo features the dark blue, italicized text \"NASPGHAN\" on a blue gradient background, with a dark blue curved line underneath.::>\n\n<a id='e24ede4b-28f4-422f-8d9d-a456d3220f06'></a>\n\nCase Review Cont'd\n\n<a id='d74315ce-3ebb-4734-be3a-b83150a0808b'></a>\n\nLucy is a 5-month-old with biliary atresia and progressive end stage liver\ndisease who is listed for transplant. She has been admitted on the GI ward\nfor emergency admission and management of malnutrition and\nhypoglycemia.\n\n2) Would you recommend parenteral nutrition and when?\nShould recommence enteral nutrition support ideally within 24h\nand plan to advance to meet 60% of expected or ideally measured\nenergy requirements within a week. However, if not meeting daily\ngoals for EN deliver or experiencing significant feeding intolerance\nreasonable to consider starting PN in 72h\n\n1) [illegible]\n2) Would you recommend parenteral nutrition and when?\n3) What factors would influence the energy requirements of this patient?\n\n<a id='df9c0e3a-80d5-4cc6-9098-248f86bc96ef'></a>\n\n<::NASPGHAN FOUNDATION\n: figure::>\n\n<a id='95636053-c724-4c0f-b281-3cffd6a7fda8'></a>\n\n<::logo: NASPGHAN\nNASPGHAN\nThe logo features dark blue, italicized text \"NASPGHAN\" on a blue gradient background, with a dark blue curved line underneath.::>\n\n<a id='7a02331a-0056-4c9a-89fb-7e73fc51a505'></a>\n\nCase Review Cont'd\n\n<a id='4cca289f-5046-485b-a49e-9055b1a5b5b1'></a>\n\nLucy is a 5-month-old with biliary atresia and progressive end stage liver disease who is listed for transplant. She has been admitted on the GI ward\n\n3) What factors would influence the energy requirements of this patient?\noption Energy requirements are generally increased in liver failure: [x]\noption Sepsis can also increase energy requirements: [x]\noption Sedation and mechanical ventilation will both decrease energy needs: [x]\noption NPO and use of PN will also decrease total energy requirements: [x]\n\n1) What information would you like to assess her nutrition?\n2) Would you recommend parenteral nutrition and when?\n3) What factors would influence the energy requirements of this patient?\n\n<a id='da34bc69-6618-47a7-a65f-773452bb0f61'></a>\n\n<::NASPGHAN FOUNDATION\n: figure::>\n\n<a id='eeddfdb6-e47e-4dac-9201-207177434831'></a>\n\nCAPTION ERROR",
      "chunks": [
        "b6ecb705-d02b-4b29-9b73-7bd9e147f628",
        "3f25d752-6eea-4504-ba31-457a10ea6d1b",
        "4d0458ea-f232-43b0-b12f-223bafccec0a",
        "2a581be9-5687-4bb8-bd29-1f89e2e6dd05",
        "f6e03fa9-820c-4e5c-a397-98ab55e5c604",
        "ea4058a5-ac78-489a-8b11-e8e6d1458c6e",
        "d270c4cf-072b-444d-9f6a-62dfa45d2f51",
        "1a2595a1-df51-41be-b60f-7d85f5f13a91",
        "32889cfe-4935-48e1-ad7b-1c9e72835218",
        "d59186bf-bc7c-4843-9663-c35e33a24488",
        "a206841d-ab19-43b7-9fba-db7138509a3b",
        "1d4ee8ad-5aa7-40a9-9c69-a8937277e72e",
        "d5cd2621-791c-4746-844e-fc0939eb9aa5",
        "21898e66-f55d-4f31-8ff4-c6560d8f9c41",
        "8c4b4004-08fe-4ea1-9e90-03ae9a638659",
        "5b69ca3d-d693-48cf-abf4-a128767b9105",
        "4eac19e0-ea94-4853-8b5f-517c818b201b",
        "802835d2-4bdb-449f-bcbf-b73fe8debed8",
        "229f6f3c-5ac0-4d6b-97d2-9a992e52b520",
        "c710f76c-765f-4bc2-aeca-bdb26840bdb5",
        "26f3cce6-a6ec-4353-87c3-184eaaeb0e46",
        "f4d0e5b7-5ba6-47ea-897e-d39a9dfb255d",
        "06315174-9d22-4771-93ce-6729350937b7",
        "9b0a35bb-9c25-4269-9c09-82581c55e3c7",
        "f357e6e0-8a21-48a2-927c-36a0d14045ff",
        "97ee7fbc-8e6a-43cc-975c-90dfd6434ef7",
        "a2e7ab1c-6bd8-4a1f-b924-1f2bd19517af",
        "c5ce4245-51bb-468e-9cb6-dbecaa21eec3",
        "5f193882-2745-4028-9cac-b2c7b3ed0b1f",
        "cd5efe5d-99fb-42fb-9cb0-f9ee579a5bc0",
        "26e5838f-2ff6-4092-a4e6-26a9b208dbfe",
        "a06e1c3b-cb6e-4a28-ba5e-6f636bac1f97",
        "b5f31991-eeb7-4153-98a7-419f75e12005",
        "6d4a63c5-75b8-45f8-ade5-63f11ec2e5f7",
        "6983e46a-a8f9-4898-99ca-2292ae1303c1",
        "e24ede4b-28f4-422f-8d9d-a456d3220f06",
        "d74315ce-3ebb-4734-be3a-b83150a0808b",
        "df9c0e3a-80d5-4cc6-9098-248f86bc96ef",
        "95636053-c724-4c0f-b281-3cffd6a7fda8",
        "7a02331a-0056-4c9a-89fb-7e73fc51a505",
        "4cca289f-5046-485b-a49e-9055b1a5b5b1",
        "da34bc69-6618-47a7-a65f-773452bb0f61",
        "eeddfdb6-e47e-4dac-9201-207177434831"
      ]
    }
  ],
  "grounding": {
    "b6ecb705-d02b-4b29-9b73-7bd9e147f628": {
      "box": {
        "left": 0.06821951270103455,
        "top": 0.09378895908594131,
        "right": 0.8928407430648804,
        "bottom": 0.18533235788345337
      },
      "page": 0,
      "type": "chunkText"
    },
    "3f25d752-6eea-4504-ba31-457a10ea6d1b": {
      "box": {
        "left": 0.06594036519527435,
        "top": 0.21393156051635742,
        "right": 0.5121729969978333,
        "bottom": 0.8586722612380981
      },
      "page": 0,
      "type": "chunkText"
    },
    "4d0458ea-f232-43b0-b12f-223bafccec0a": {
      "box": {
        "left": 0.5416315793991089,
        "top": 0.20940187573432922,
        "right": 0.9348140954971313,
        "bottom": 0.8764520883560181
      },
      "page": 0,
      "type": "chunkFigure"
    },
    "2a581be9-5687-4bb8-bd29-1f89e2e6dd05": {
      "box": {
        "left": 0.00045027583837509155,
        "top": 0.8965668678283691,
        "right": 0.1548824906349182,
        "bottom": 0.9983819723129272
      },
      "page": 0,
      "type": "chunkFigure"
    },
    "f6e03fa9-820c-4e5c-a397-98ab55e5c604": {
      "box": {
        "left": 0.16332238912582397,
        "top": 0.913303554058075,
        "right": 0.45221132040023804,
        "bottom": 0.9615463614463806
      },
      "page": 0,
      "type": "chunkText"
    },
    "ea4058a5-ac78-489a-8b11-e8e6d1458c6e": {
      "box": {
        "left": 0.642351508140564,
        "top": 0.8726059794425964,
        "right": 0.8599236011505127,
        "bottom": 0.9092616438865662
      },
      "page": 0,
      "type": "chunkText"
    },
    "d270c4cf-072b-444d-9f6a-62dfa45d2f51": {
      "box": {
        "left": 0.8062930107116699,
        "top": 0.895202100276947,
        "right": 0.9973379373550415,
        "bottom": 0.999583899974823
      },
      "page": 0,
      "type": "chunkLogo"
    },
    "1a2595a1-df51-41be-b60f-7d85f5f13a91": {
      "box": {
        "left": 0.06475400924682617,
        "top": 0.10816587507724762,
        "right": 0.47577887773513794,
        "bottom": 0.2736901044845581
      },
      "page": 1,
      "type": "chunkText"
    },
    "32889cfe-4935-48e1-ad7b-1c9e72835218": {
      "box": {
        "left": 0.06796503067016602,
        "top": 0.3211227059364319,
        "right": 0.8049461245536804,
        "bottom": 0.5625595450401306
      },
      "page": 1,
      "type": "chunkText"
    },
    "d59186bf-bc7c-4843-9663-c35e33a24488": {
      "box": {
        "left": 0.06891018152236938,
        "top": 0.5991585850715637,
        "right": 0.9284107685089111,
        "bottom": 0.8322474360466003
      },
      "page": 1,
      "type": "chunkText"
    },
    "a206841d-ab19-43b7-9fba-db7138509a3b": {
      "box": {
        "left": 0.0004724264144897461,
        "top": 0.8985068202018738,
        "right": 0.15385374426841736,
        "bottom": 0.9989102482795715
      },
      "page": 1,
      "type": "chunkFigure"
    },
    "1d4ee8ad-5aa7-40a9-9c69-a8937277e72e": {
      "box": {
        "left": 0.16370706260204315,
        "top": 0.9119826555252075,
        "right": 0.5361854434013367,
        "bottom": 0.9597796201705933
      },
      "page": 1,
      "type": "chunkText"
    },
    "d5cd2621-791c-4746-844e-fc0939eb9aa5": {
      "box": {
        "left": 0.8060640096664429,
        "top": 0.8947970271110535,
        "right": 0.9978591203689575,
        "bottom": 0.9997079968452454
      },
      "page": 1,
      "type": "chunkLogo"
    },
    "21898e66-f55d-4f31-8ff4-c6560d8f9c41": {
      "box": {
        "left": 0.06251382827758789,
        "top": 0.10470589995384216,
        "right": 0.9192966222763062,
        "bottom": 0.6845964193344116
      },
      "page": 2,
      "type": "chunkText"
    },
    "8c4b4004-08fe-4ea1-9e90-03ae9a638659": {
      "box": {
        "left": 0.0003286302089691162,
        "top": 0.897782027721405,
        "right": 0.15225020051002502,
        "bottom": 0.9992154240608215
      },
      "page": 2,
      "type": "chunkFigure"
    },
    "5b69ca3d-d693-48cf-abf4-a128767b9105": {
      "box": {
        "left": 0.16136549413204193,
        "top": 0.8928555250167847,
        "right": 0.5391477346420288,
        "bottom": 0.9975388050079346
      },
      "page": 2,
      "type": "chunkText"
    },
    "4eac19e0-ea94-4853-8b5f-517c818b201b": {
      "box": {
        "left": 0.8055374026298523,
        "top": 0.8962593078613281,
        "right": 0.9983918070793152,
        "bottom": 0.9997262954711914
      },
      "page": 2,
      "type": "chunkLogo"
    },
    "802835d2-4bdb-449f-bcbf-b73fe8debed8": {
      "box": {
        "left": 0.06367933750152588,
        "top": 0.10384915769100189,
        "right": 0.8908818960189819,
        "bottom": 0.530711829662323
      },
      "page": 3,
      "type": "chunkText"
    },
    "229f6f3c-5ac0-4d6b-97d2-9a992e52b520": {
      "box": {
        "left": 0.0692303478717804,
        "top": 0.5710016489028931,
        "right": 0.9251737594604492,
        "bottom": 0.8231790065765381
      },
      "page": 3,
      "type": "chunkText"
    },
    "c710f76c-765f-4bc2-aeca-bdb26840bdb5": {
      "box": {
        "left": 0.00039771199226379395,
        "top": 0.8972253203392029,
        "right": 0.15179015696048737,
        "bottom": 0.9992945790290833
      },
      "page": 3,
      "type": "chunkFigure"
    },
    "26f3cce6-a6ec-4353-87c3-184eaaeb0e46": {
      "box": {
        "left": 0.16185934841632843,
        "top": 0.8927229642868042,
        "right": 0.5390763282775879,
        "bottom": 0.997846245765686
      },
      "page": 3,
      "type": "chunkText"
    },
    "f4d0e5b7-5ba6-47ea-897e-d39a9dfb255d": {
      "box": {
        "left": 0.8052676916122437,
        "top": 0.8951627612113953,
        "right": 0.998414158821106,
        "bottom": 0.9996880888938904
      },
      "page": 3,
      "type": "chunkLogo"
    },
    "06315174-9d22-4771-93ce-6729350937b7": {
      "box": {
        "left": 0.06245806813240051,
        "top": 0.10587182641029358,
        "right": 0.9247637987136841,
        "bottom": 0.8017771244049072
      },
      "page": 4,
      "type": "chunkText"
    },
    "9b0a35bb-9c25-4269-9c09-82581c55e3c7": {
      "box": {
        "left": 0.0003002285957336426,
        "top": 0.8995340466499329,
        "right": 0.15346208214759827,
        "bottom": 0.9984896779060364
      },
      "page": 4,
      "type": "chunkText"
    },
    "f357e6e0-8a21-48a2-927c-36a0d14045ff": {
      "box": {
        "left": 0.1642737090587616,
        "top": 0.9128892421722412,
        "right": 0.5352658033370972,
        "bottom": 0.9591253995895386
      },
      "page": 4,
      "type": "chunkText"
    },
    "97ee7fbc-8e6a-43cc-975c-90dfd6434ef7": {
      "box": {
        "left": 0.8064997792243958,
        "top": 0.896197497844696,
        "right": 0.9977017045021057,
        "bottom": 0.9995390772819519
      },
      "page": 4,
      "type": "chunkLogo"
    },
    "a2e7ab1c-6bd8-4a1f-b924-1f2bd19517af": {
      "box": {
        "left": 0.06726927310228348,
        "top": 0.10347624123096466,
        "right": 0.16528275609016418,
        "bottom": 0.17649449408054352
      },
      "page": 5,
      "type": "chunkLogo"
    },
    "c5ce4245-51bb-468e-9cb6-dbecaa21eec3": {
      "box": {
        "left": 0.06566044688224792,
        "top": 0.23982617259025574,
        "right": 0.967273473739624,
        "bottom": 0.5444543361663818
      },
      "page": 5,
      "type": "chunkText"
    },
    "5f193882-2745-4028-9cac-b2c7b3ed0b1f": {
      "box": {
        "left": 0.0797649621963501,
        "top": 0.5974393486976624,
        "right": 0.9643352031707764,
        "bottom": 0.8133531212806702
      },
      "page": 5,
      "type": "chunkText"
    },
    "cd5efe5d-99fb-42fb-9cb0-f9ee579a5bc0": {
      "box": {
        "left": 0.0001544356346130371,
        "top": 0.8970438838005066,
        "right": 0.15438024699687958,
        "bottom": 0.9992749094963074
      },
      "page": 5,
      "type": "chunkFigure"
    },
    "26e5838f-2ff6-4092-a4e6-26a9b208dbfe": {
      "box": {
        "left": 0.8047690391540527,
        "top": 0.8942133784294128,
        "right": 0.9988257884979248,
        "bottom": 0.9997617602348328
      },
      "page": 5,
      "type": "chunkLogo"
    },
    "a06e1c3b-cb6e-4a28-ba5e-6f636bac1f97": {
      "box": {
        "left": 0.06767409294843674,
        "top": 0.09902749955654144,
        "right": 0.3092477321624756,
        "bottom": 0.17833875119686127
      },
      "page": 6,
      "type": "chunkText"
    },
    "b5f31991-eeb7-4153-98a7-419f75e12005": {
      "box": {
        "left": 0.06679633259773254,
        "top": 0.23899877071380615,
        "right": 0.9666863679885864,
        "bottom": 0.812995433807373
      },
      "page": 6,
      "type": "chunkText"
    },
    "6d4a63c5-75b8-45f8-ade5-63f11ec2e5f7": {
      "box": {
        "left": 0.00015389174222946167,
        "top": 0.895706057548523,
        "right": 0.15380513668060303,
        "bottom": 0.9995803833007812
      },
      "page": 6,
      "type": "chunkText"
    },
    "6983e46a-a8f9-4898-99ca-2292ae1303c1": {
      "box": {
        "left": 0.8054748773574829,
        "top": 0.892585813999176,
        "right": 0.9982607364654541,
        "bottom": 0.9998438954353333
      },
      "page": 6,
      "type": "chunkLogo"
    },
    "e24ede4b-28f4-422f-8d9d-a456d3220f06": {
      "box": {
        "left": 0.06822560727596283,
        "top": 0.09589503705501556,
        "right": 0.42074233293533325,
        "bottom": 0.18239276111125946
      },
      "page": 7,
      "type": "chunkText"
    },
    "d74315ce-3ebb-4734-be3a-b83150a0808b": {
      "box": {
        "left": 0.06651273369789124,
        "top": 0.2409127950668335,
        "right": 0.966292142868042,
        "bottom": 0.8104273080825806
      },
      "page": 7,
      "type": "chunkText"
    },
    "df9c0e3a-80d5-4cc6-9098-248f86bc96ef": {
      "box": {
        "left": 0.00012126564979553223,
        "top": 0.8968214988708496,
        "right": 0.15453636646270752,
        "bottom": 0.9994776248931885
      },
      "page": 7,
      "type": "chunkFigure"
    },
    "95636053-c724-4c0f-b281-3cffd6a7fda8": {
      "box": {
        "left": 0.8047931790351868,
        "top": 0.8936476111412048,
        "right": 0.9984483122825623,
        "bottom": 0.9997597336769104
      },
      "page": 7,
      "type": "chunkLogo"
    },
    "7a02331a-0056-4c9a-89fb-7e73fc51a505": {
      "box": {
        "left": 0.06784297525882721,
        "top": 0.09457655996084213,
        "right": 0.4217453598976135,
        "bottom": 0.18201130628585815
      },
      "page": 8,
      "type": "chunkText"
    },
    "4cca289f-5046-485b-a49e-9055b1a5b5b1": {
      "box": {
        "left": 0.06520622968673706,
        "top": 0.24003693461418152,
        "right": 0.9668915867805481,
        "bottom": 0.8125436305999756
      },
      "page": 8,
      "type": "chunkText"
    },
    "da34bc69-6618-47a7-a65f-773452bb0f61": {
      "box": {
        "left": 3.2573938369750977e-05,
        "top": 0.8971733450889587,
        "right": 0.15463882684707642,
        "bottom": 0.9995041489601135
      },
      "page": 8,
      "type": "chunkFigure"
    },
    "eeddfdb6-e47e-4dac-9201-207177434831": {
      "box": {
        "left": 0.8047940135002136,
        "top": 0.8939814567565918,
        "right": 0.9987171292304993,
        "bottom": 0.999727725982666
      },
      "page": 8,
      "type": "chunkLogo"
    }
  },
  "metadata": {
    "filename": "8PN PN for Specialized Patient_part2.pdf",
    "org_id": null,
    "page_count": 9,
    "duration_ms": 12531,
    "credit_usage": 27.0,
    "job_id": "fyraxy1ziy6ziyv5s3bdfna2h",
    "version": "dpt-2-20250919"
  }
}